[HTML][HTML] Use of glucose-lowering agents in diabetes and CKD
RZ Alicic, JJ Neumiller, RJ Galindo, KR Tuttle - Kidney international reports, 2022 - Elsevier
Diabetes is the most common cause of kidney failure worldwide. Patients with diabetes and
chronic kidney disease (CKD) are also at markedly higher risk of cardiovascular disease …
chronic kidney disease (CKD) are also at markedly higher risk of cardiovascular disease …
Overview of atypical diabetes
J Tamaroff, M Kilberg, SE Pinney… - Endocrinology and …, 2020 - endo.theclinics.com
Although a majority of children and adults with diabetes mellitus (DM) are diagnosed with
type 1 diabetes mellitus (T1D) or type 2 diabetes mellitus (T2D), a significant number of …
type 1 diabetes mellitus (T1D) or type 2 diabetes mellitus (T2D), a significant number of …
RSSDI consensus recommendations on insulin therapy in the management of diabetes
R Chawla, BM Makkar, S Aggarwal, S Bajaj… - International Journal of …, 2019 - Springer
Abstract The Research Society for the Study of Diabetes in India (RSSDI) has regularly
updated its Clinical Practice Guidelines on various aspects of diabetes. The …
updated its Clinical Practice Guidelines on various aspects of diabetes. The …
[HTML][HTML] Label-free mass spectrometry-based quantitative proteomics to evaluate the effects of the calcium-sensing receptor agonist cinacalcet on protein expression …
E Bulska, A Gawor, A Konopka, G Wryk… - … Medical Journal of …, 2022 - ncbi.nlm.nih.gov
Background Cinacalcet is a calcium-sensing receptor agonist that is clinically approved for
the treatment of secondary hyperparathyroidism in chronic kidney disease and …
the treatment of secondary hyperparathyroidism in chronic kidney disease and …
[HTML][HTML] The 2021–2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice …
Background Diabetic kidney disease is the leading cause of end-stage renal disease and is
associated with increased morbidity and mortality. This review is an authorized literal …
associated with increased morbidity and mortality. This review is an authorized literal …
Clinical assessment and treatment of diabetes in patients with chronic kidney disease
JC Gómez, JCA Lorido - Revista Clínica Española (English Edition), 2018 - Elsevier
Diabetes mellitus type 2 is the main cause of chronic kidney disease. Patients with this
disease have higher morbidity and mortality and risk of hypoglycaemia than those without …
disease have higher morbidity and mortality and risk of hypoglycaemia than those without …
[HTML][HTML] Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the …
Chronic kidney disease (CKD) is a common complication of type 2 diabetes (T2D) that, in
insulin-treated people can result in decreased insulin clearance and increased risk of …
insulin-treated people can result in decreased insulin clearance and increased risk of …
Pengaruh Faktor Internal dan Faktor Eksternal Obat Terhadap Keputusan Konsumen Dalam Memilih Obat Swamedikasi di Apotik S, Tangerang Selatan
Swamedikasi adalah praktik di mana individu secara mandiri memilih dan menggunakan
obat-obatan tanpa resep dokter untuk mengatasi kondisi kesehatan mereka. Faktor internal …
obat-obatan tanpa resep dokter untuk mengatasi kondisi kesehatan mereka. Faktor internal …
Glycemic Control
AA Krikorian, APP Calimag - Diabetes and Kidney Disease, 2022 - Springer
The prevalence of chronic kidney disease in patients with diabetes continues to increase.
Management of these patients is quite challenging, as it needs a comprehensive and …
Management of these patients is quite challenging, as it needs a comprehensive and …
Basal insulin analogues in people with diabetes and chronic kidney disease
D León‐Jiménez, JP Miramontes‐González… - Diabetic …, 2022 - Wiley Online Library
Background Diabetic kidney disease is the leading cause of chronic kidney disease (CKD)
and end‐stage kidney disease (ESKD) worldwide. ESKD has a high prevalence in patients …
and end‐stage kidney disease (ESKD) worldwide. ESKD has a high prevalence in patients …